Your browser doesn't support javascript.
loading
Risk Factors for Rectal Cancer Recurrence after Local Excision of T1 Lesions from a Decade-Long Multicenter Retrospective Study.
Rudnicki, Yaron; Goldberg, Nitzan; Horesh, Nir; Harbi, Assaf; Lubianiker, Barak; Green, Eraan; Raveh, Guy; Slavin, Moran; Segev, Lior; Gilshtein, Haim; Barenboim, Alexander; Wasserberg, Nir; Khaikin, Marat; Tulchinsky, Hagit; Issa, Nidal; Duek, Daniel; Avital, Shmuel; White, Ian.
Afiliação
  • Rudnicki Y; Department of Surgery, Meir Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Goldberg N; Department of Surgery, Meir Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Horesh N; Department of General Surgery B and Organ Transplantation, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Harbi A; Department of General Surgery, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel.
  • Lubianiker B; Department of Surgery, Rabin Medical Center-Hasharon Hospital, Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
  • Green E; Department of Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Raveh G; Department of Surgery, Rabin Medical Center-Beilinson Hospital, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Slavin M; Department of Surgery, Meir Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Segev L; Department of General Surgery B and Organ Transplantation, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Gilshtein H; Department of General Surgery, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel.
  • Barenboim A; Department of Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Wasserberg N; Department of Surgery, Rabin Medical Center-Beilinson Hospital, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Khaikin M; Department of General Surgery B and Organ Transplantation, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Tulchinsky H; Department of Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Issa N; Department of Surgery, Rabin Medical Center-Hasharon Hospital, Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
  • Duek D; Department of General Surgery, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel.
  • Avital S; Department of Surgery, Meir Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • White I; Department of Surgery, Rabin Medical Center-Beilinson Hospital, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
J Clin Med ; 13(14)2024 Jul 16.
Article em En | MEDLINE | ID: mdl-39064178
ABSTRACT

Background:

Local surgical excision of T1 rectal adenocarcinoma is a well-established approach. Yet, there are still open questions regarding the recurrence rates and its risk factors.

Methods:

A retrospective multicenter study including all patients who underwent local excision of early rectal cancer with an open or MIS approach and had a T1 lesion from 2010 to 2020 in six academic centers. Data included demographics, preoperative studies, surgical findings, postoperative outcomes, and local and systemic recurrence. A univariable and multivariable logistic regression analysis was performed to identify risk factors for recurrence.

Results:

Overall, 274 patients underwent local excision of rectal lesions. Of them, 97 (35.4%) patients with a T1 lesion were included in the cohort. The mean age was 69 ± 10.5 years, and 42 (43.3%) were female. The mean distance of the lesions from the anal verge was 7.8 ± 3.2 cm, and the average tumor size was 2.7 ± 1.6 cm. Eighty-two patients (85%) had a full-thickness resection. Eight patients (8%) had postoperative complications. Kikuchi classification of submucosal (SM) involvement was reported in 29 (30%) patients. Twelve patients had SM1, two SM2, and fifteen SM3. Following pathology, 24 patients (24.7%) returned for additional surgery or treatment. The overall recurrence rate was 14.4% (14 patients), with 11 patients having a local recurrence and 6 having a systemic metastatic recurrence, 3 of which had both. The mean time for recurrence was 2.78 ± 2.8 years and the overall mortality rate was 11%. On univariable and multivariable logistic regression analysis of recurrence vs. non-recurrence groups, the strongest and most significant association and possible risk factors for recurrence were larger lesions (4.3 vs. 2.5 cm, p < 0.001) with an OR of 6.67 (CI-1.82-24.36), especially for tumors larger than 3.5 cm, mucinous histology (14.3% vs. 1.2%, p = 0.004, OR of 14.02, CI-1.13-173.85), and involved margins (41.7% vs. 16.2%, p = 0.003, OR of 9.59, CI-2.14-43.07). The open transanal excision (TAE) approach was also identified as a possible significant risk factor in univariant analysis, while SM3 level penetration showed only a trend.

Conclusion:

Surgical local excision of T1 rectal malignancy is a safe and viable option. Still, one in four patients received additional treatment. There is an almost 15% chance for recurrence, especially in large tumors, mucinous histology, or involved margin cases. These high-risk patients might warrant additional intervention and stricter surveillance protocols.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2024 Tipo de documento: Article